TrialJournal of Crohn's & colitis2024

Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis.

Mina Hassan-Zahraee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.